Comparison of three techniques for generation of tolerogenic dendritic cells: siRNA, oligonucleotide antisense, and antibody blocking

Hybridoma

Volumn 29, Issue 6, 2010, Pages 473-480

  Karimi, Mohammad Hossein ^a   Ebadi, Padideh ^b   Pourfathollah, Ali Akbar ^c   Moazzeni, Mohammad ^c   Soheili, Zahra Soheila ^d   Samiee, Shahram ^e  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c TARBIAT MODARES UNIVERSITY   (Iran)

^d Institute of Genetic Engineering and Biotechnology   (Iran)

^e HIGH INSTITUTE FOR RESEARCH AND EDUCATION IN TRANSFUSION MEDICINE   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CD40 ANTIGEN; CD40 LIGAND MONOCLONAL ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 4; LIPOFECTAMINE; MESSENGER RNA; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CELL ISOLATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSFECTION; IMMUNOSTIMULATION; IN VITRO STUDY; INTERMETHOD COMPARISON; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN CELL; TOLEROGENIC DENDRITIC CELL;

ANIMALS; ANNEXIN A5; ANTIBODIES, BLOCKING; ANTIGENS, CD40; CELL LINE, TUMOR; CELLS, CULTURED; DENDRITIC CELLS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; IMMUNE TOLERANCE; LIPIDS; MICE; OLIGONUCLEOTIDES, ANTISENSE; POLYMERASE CHAIN REACTION; PROPIDIUM; RNA, SMALL INTERFERING;

EID: 78650163032     PISSN: 15540014     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.2010.0060     Document Type: Article

References (49)

1. Steinman RM, Adams JC, and Cohn ZA: Identification of a novel cell type in peripheral lymphoid organs of mice. IV. Identification and distribution in mouse spleen. J Exp Med 1975;141:804-820.
2. Li M, Qian H, Ichim TE, Ge WW, Popov IA, Rycerz K, Neu J, White D, Zhong R, and Min WP: Induction of RNA interference in dendritic cells. Immunol Res 2004;30:215-230. (Pubitemid 39425344)
3. Mailliard RB, Son YI, Redlinger R Coates PT, Giermasz A, Morel PA, Storkus WJ, and Kalinski P: Dendritic cells mediate NK cell help for Th1 and CTL responses: Two signal requirements for the induction of NK cell helper function. J Immunol 2003;171:2366-2373. (Pubitemid 37025543)
4. Nishimura T, Kitamura H, Iwakabe K Yahata T, Ohta A, Sato M, Takeda K, Okumura K, Van Kaer L, Kawano T, Taniguchi M, Nakui M, Sekimoto M, and Koda T: The interface between innate and acquired immunity: Glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes. Int Immunol 2000;12:987-994. (Pubitemid 30601366)
5. Lechler R, Ng WF, and Steinman RM: Dendritic cell in transplantation- friend or foe? Immunity 2001;14:357-368.
6. Liang X, Lu L, Chen Z, Vickers T, Zhang H, Fung JJ, and Qian S: Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival. Transplantation 2003;76:721-729. (Pubitemid 37072011)
7. Morel Y, Truneh A, Sweet RW, Olive D, and Costello RT: The TNF superfamily members LIGHT and CD154 (CD40 ligand) co-stimulate induction of dendritic cell maturation and elicit specific CTL activity. J Immunol 2001;167:2479-2486. (Pubitemid 32768873)
8. Steinman RM, Hawiger D, and Nussenzweig MC: Tolerogenic dendritic cells. Annu Rev Immunol 2003;21:685-711. (Pubitemid 37174545)
9. Morelli AE, and Thomson AW: Dendritic cells: Regulators of alloimmunity and opportunities for tolerance induction. Immunol Rev 2003;196:125-146. (Pubitemid 37468108)
10. Zamecnik PC, and Stephenson ML: Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc Natl Acad Sci USA 1978;75:280-284. (Pubitemid 8290783)
11. Kurreck J: Antisense technologies improvement through novel chemical modifications. Eur J Biochem 2003;270:1628-1644. (Pubitemid 36532522)
12. Meister G, and Tuschl T: Mechanisms of gene silencing by double stranded RNA. Nature 2004;431:343-349. (Pubitemid 39265674)
13. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, and Tuschl T: Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001;411:494-498. (Pubitemid 32494397)
14. Corey DR: RNA learns from antisense. Nat Chem Biol 2007;3:8-11. (Pubitemid 46005687)
15. Hannon GJ: RNA interference. Nature 2002;418:244-251. (Pubitemid 34773784)
16. Dorsett Y, and Tuschl T: SiRNAs: Applications in functional genomics and potential as therapeutics. Nat Rev Drug Discov 2004;3:318-329. (Pubitemid 38499759)
17. Li XL, Menoret S, Mauff BL, Angin M, and Anegon I: Promises and obstacles for the blockade of CD40-CD40L interaction in allotransplantation. Transplantation 2008;86: 10-15.
18. Siwkowski AM, Malik L, Esau CC, Maier MA, Wancewicz EV, Albertshofer K, Monia BP, Bennett CF, and Eldrup AB: Identification and functional validation of PNAs that inhibit murine CD40 expression by redirection of splicing. Nucleic Acids Res 2004;32:2695-2706. (Pubitemid 38885941)
19. Karimi MH, Ebadi P, Pourfathollah AA, Soheili ZS, Samiee Sh, Ataee Z, Tabei SZ, and Moazzeni SM: Immune modulation through RNA interference-mediated silencing of CD40 in dendritic cells. Cell Immunol 2009;259:74-81.
20. Karimi MH, Ebadi P, Pourfathollah AA, Soheili ZS, Samiee Sh, Ataee Z, Tabei SZ, Nadali F, and Moazzeni SM: Tolerance induction by CD40 silenced dendritic cells through antisense. Iran Red Cres Med J 2009;11:1-9.
21. Min WP, Gorczynski R, Huang XY, Kushida M, Kim P, Obataki M, Lei J, Suri RM, and Cattral MS: Dendritic cells genetically engineered to express Fas ligand induce donorspecific hyporesponsiveness and prolong allograft survival. J Immunol 2000;164:161-167. (Pubitemid 30012986)
22. Ebadi P, Karimi MH, Pourfathollah AA, Saheb Ghadam Lotfi A, Soheili ZS, Moazzeni SM, Samiee S, Hajati E, Nadali F, and Geramizadeh B: The efficiency of CD40 down regulation by siRNA and antisense ODN: Comparison of Lipofectamine and FuGENE6. Iran J Immunol 2009;6:1-11.
23. McManus MT, Haines BB, Dillon CP, Whitehurst CE, Van Parijs L, Chen J, and Sharp PA: Small interfering RNAmediated gene silencing in T lymphocytes. J Immunol 2002;169:5754-5760. (Pubitemid 35291677)
24. Trinchieri G: Interleukin-12: A cytokine at the interface of inflammation and immunity. Adv Immunol 1998;70:83-243. (Pubitemid 128678837)
25. Banchereau J, and Steinman RM: Dendritic cells and the control of immunity. Nature 1998;392:245-252. (Pubitemid 28155090)
26. Popescu FD: Antisense and RNA interference-based therapeutic strategies in allergy. J Cell Mol Med 2005;9:840-853.
27. Vincenti F: Costimulation blockade in autoimmunity and transplantation. J Allergy Clin Immunol 2008;121:299-306. (Pubitemid 351215188)
28. Scherer LJ, and Rossi JJ: Approaches for the sequencespecific knockdown of mRNA. Nat Biotechnol 2003;21:1457-1465.
29. Hill JA, Ichim TE, Kusznieruk KP, Li M, Huang X, Yan X, Zhong R, Cairns E, Bell DA, and Min WP: Immune modulation by silencing IL-12 production in dendritic cells using small interfering RNA. J Immunol 2003;171:691-696. (Pubitemid 36871378)
30. Braasch DA, and Corey DR: Novel antisense and peptide nucleic acid strategies for controlling gene expression. Biochemistry 2002;41:4503-4510. (Pubitemid 34275650)
31. Ford ML, and Larsen CP: Translating co-stimulation blockade to the clinic: Lessons learned from three pathways. Immunol Rev 2009;229:294-306.
32. Mauri C, Mars LT, and Londei M: Therapeutic activity of agonistic monoclonal antibodies against CD40 in a chronic autoimmune inflammatory process. Nat Med 2000;6:673-679. (Pubitemid 30398791)
33. McGregor CM, Schoenberger SP, and Green EA: CD154 is a negative regulator of autoaggressive CD8+ T cells in type 1 diabetes. Proc Natl Acad Sci USA 2004;101:9345-9350. (Pubitemid 38812878)
34. Liu G, Ng H, Akasaki Y, Yuan X, Ehtesham M, Yin D, Black KL, and Yu JS: Small interference RNA modulation of IL-10 in human monocyte-derived dendritic cells enhances the Th1 response. Eur J Immunol 2004;34:1680-1687. (Pubitemid 39256050)
35. Suzuki M, Zheng X, Zhang X, Zhang Z, Ichim TE, Sun H, Nakamura Y, Inagaki A, Beduhn M, Shunnar A, Garcia B, and Min WP: A novel allergen-specific therapy for allergy using CD40-silenced dendritic cells. J Allergy Clin Immunol 2010;125:737-743.
36. Xiang J, Gu X, Zhou Y, Gong X, Qian S, and Chen Z: Administration of dendritic cells modified by RNA interference prolongs cardiac allograft survival. Microsurgery 2007; 27(4):320-323. (Pubitemid 46897039)
37. Stax AM, Crul C, Kamerling SW, Schlagwein N, van der Geest RN, Woltman AM, and van Kooten C: CD40L stimulation of rat dendritic cells specifically favors the IL-12/IL- 10 ratio resulting in a strong T cell stimulatory capacity. Mol Immunol 2008;45:2641-2650.
38. Xu Y, Zhang HY, Thormeyer D, Larsson O, Du Q, Elmen J, Wahlestedt C, and Liang Z: Effective small interfering RNAs and phosphorothioate antisense DNAs have different preferences for target sites in the luciferase mRNAs. Biochem Biophys Res Commun 2003;306:712-717. (Pubitemid 37323820)
39. Grünweller A, Wyszko E, Bieber B, Jahnel R, Erdmann VA, and Kurreck J: Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2-O-methyl RNA, phosphorothioates and small interfering RNA. Nucleic Acids Res 2003;31:3185-3193. (Pubitemid 37441778)
40. Hiroi N, Funahashi A, and Kitano H: Comparative studies of suppression of malignant cancer cell phenotype by antisense oligo DNA and small interfering RNA. Cancer Gene Ther 2006;13:7-12. (Pubitemid 41816344)
41. Miyagishi M, Hayashi M, and Taira K: Comparison of the suppressive effects of antisense oligonucleotides and siRNAs directed against the same targets in mammalian cells. Antisense Nucleic Acid Drug Dev 2003;13:1-7.
42. Bilanges B, and Stokoe D: Direct comparison of the specificity of gene silencing using antisense oligonucleotides and RNAi. Biochem J 2005;388:573-583. (Pubitemid 40839935)
43. Chi JT, Chang HY, Wang NN, Chang DS, Dunphy N, and Brown PO: Genome wide view of gene silencing by small interfering RNAs. Proc Natl Acad Sci USA 2003;100:6343-6346. (Pubitemid 36666583)
44. Bertrand JR, Pottier M, Vekris A, Opolon P, Maksimenko A, and Malvy C: Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo. Biochem Biophys Res Commun 2002;296:1000-1004.
45. Vickers TA, Koo S, Bennett CF, Crook ST, Dean NM, and Baker BF: Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. J Biol Chem 2003;278:7108-7118. (Pubitemid 36800708)
46. Zhang L, Procuik M, Fang T, and Kung SK: Functional analysis of the quantitative expression of a co-stimulatory molecule on dendritic cells using lentiviral vector-mediated RNA interference. J Immunol Methods 2009;344:87-97.
47. Gewirtz AM: Oligonucleotide therapeutics: Clothing the emperor. Curr Opin Mol Ther 1999;1:297-306. (Pubitemid 29309177)
48. Drewe E, and Powell RJ: Clinically useful monoclonal antibodies in treatment. J Clin Pathol 2002;55:81-85. (Pubitemid 34123904)
49. Martinez J, Patkaniowska A, Urlaub H, Luhrmann R, and Tuschl T: Single stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell 2002;110:563-574. (Pubitemid 35247837)